Xencor (XNCR) Cash from Operations (2013 - 2026)
Xencor's (XNCR) quarterly Cash from Operations came in at 67628000.0 in Q1 2026, down 316.94% year-on-year from 31173302.26 in Q1 2025, and down 30.78% on a QoQ basis from 51711000.0 in Q4 2025.
Xencor (XNCR) Cash from Operations (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Cash from Operations data on file, last reported at 67628000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations fell 316.94% year-over-year to 67628000.0 in Q1 2026; TTM through Mar 2026 was 186525000.0, a 15.46% decrease from a year earlier, with the FY2025 full-year figure at 135117000.0, up 33.17% from the prior year.
- Cash from Operations for Q1 2026 stood at 67628000.0, down from 51711000.0 in the prior quarter.
- Over the last five years, Cash from Operations for XNCR reached as high as 44269000.0 in Q2 2022 and fell as low as 67628000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 26963176.47 across 5 years, with a median of 30614000.0 in 2023.
- Across the five-year window, Cash from Operations surged 558.56% in 2022 and slumped 2235.7% in 2023, its largest moves.
- Year by year, Cash from Operations stood at 24431000.0 in 2022, then surged by 174.37% to 18169000.0 in 2023, then plunged by 374.3% to 49837000.0 in 2024, then dropped by 3.76% to 51711000.0 in 2025, then slumped by 30.78% to 67628000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 67628000.0 in Q1 2026, 51711000.0 in Q4 2025, and 30817000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | -67.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -67.63 Mn |
| Mar 31, 2026 | -67.63 Mn |
| Dec 31, 2025 | -51.71 Mn |
| Dec 31, 2025 | -51.71 Mn |
| Sep 30, 2025 | -30.82 Mn |
| Sep 30, 2025 | -30.82 Mn |
| Jun 30, 2025 | -36.37 Mn |
| Jun 30, 2025 | -36.37 Mn |
| Mar 31, 2025 | -16.22 Mn |
| Mar 31, 2025 | -16.22 Mn |
| Dec 31, 2024 | -49.84 Mn |
| Dec 31, 2024 | -49.84 Mn |
| Sep 30, 2024 | -28.14 Mn |
| Sep 30, 2024 | -28.14 Mn |
| Jun 30, 2024 | -67.35 Mn |
| Jun 30, 2024 | -67.35 Mn |
| Mar 31, 2024 | -56.86 Mn |
| Mar 31, 2024 | -56.86 Mn |
| Dec 31, 2023 | 18.17 Mn |
| Dec 31, 2023 | 18.17 Mn |